On January 13th, 2017, CDC published a Morbidity and Mortality Weekly Report (MMWR) article documenting a change in guidance for the assessment of poliovirus vaccination status of children who have received the poliovirus vaccine outside of the United States. The report states that documentation of poliovirus vaccination given outside of the United States is now valid only when documentation indicates receipt of either IPV or tOPV. This change applies only to those physicians assessing children within the United States and does not affect the validity of the panel physician examination. Panel physicians should continue to follow the Technical Instructions for Vaccination.
The Technical Instructions have been updated regarding the scope of the medical examination for all applicants. For details, please see the Syphilis, Gonorrhea, and Medical History and Physical Examination Technical Instructions for Panel Physicians .
2017 Intergovernmental Panel Physicians Training Summit
The 2017 Intergovernmental Panel Physician Training Summit will be held in Panama City, Panama on March 27-31, 2017! For more information, please see International Panel Physicians Association (IPPA).
As of March 28, 2016, chancroid, lymphogranuloma venerum, and granuloma inguinale are removed from the list of communicable diseases of public health significance. Therefore, evaluation for these three diseases is no longer required as part of the U.S. immigration medical screening process as of March 28, 2016. For additional information, please see Part 34 Final Rule issued on January 26, 2016.
CDC’s Antibiotic Resistance Solutions Initiative includes Quality Assurance Program activities to identify critical new interventions against multidrug-resistant tuberculosis (TB) and expand pre-migration TB screening beyond immigrants and refugees.